The same parent drug splits into two isomers, and that difference shows up in how men feel.
Clomiphene (Clomid) is a blend of two mirror-image molecules: enclomiphene and zuclomiphene. Enclomiphene is the part that helps the brain signal the testes to make more testosterone. Zuclomiphene has weak estrogen-like effects and stays in the body longer. Reviews say it can cause mood changes and other side effects. Clomiphene is approved only for women’s fertility, so use in men is off-label. Enclomiphene has no FDA-approved product, and long-term safety data are limited.
Mark is 41. Three months ago, his doctor started him on clomiphene for low testosterone, and his latest labs look promising. His numbers are up. But he doesn’t feel the way he expected. He’s short with his kids, a little flat, and some days he just feels off. Now he’s reading about enclomiphene vs. clomiphene and calling King’s Pharmacy and Compounding Center, a compounding pharmacy in Irvine, CA, with questions.
A friend at the gym first mentioned enclomiphene. Mark went online and found many strong opinions and very little plain explanation. That’s the gap this article tries to fill. We hear versions of this question often, and it deserves a clear, honest answer.
In short, these are not two unrelated drugs. Enclomiphene is one-half of clomiphene. Understanding that relationship helps explain why some men’s labs and their day-to-day experience don’t always match.
This is general education, not medical advice. Only your doctor can decide whether any change makes sense for you. If you’re still sorting out whether your symptoms point to low T in the first place, our post on the signs of low testosterone in men is a good starting point.
What Clomiphene Is: One Drug, Two Isomers
Quick take: Clomiphene citrate is not a single molecule. It’s a mixture of two isomers, enclomiphene and zuclomiphene, that share a formula but act differently in the body.
Isomers are molecules built from the same atoms arranged in different shapes. Think of a left and a right glove. They’re made of the same material, but they don’t fit the same hand.
According to a clinical overview from News-Medical, clomiphene citrate is roughly 62% enclomiphene and 38% zuclomiphene. So when a man takes clomiphene, he’s getting both isomers at once.
- Clomiphene citrate: the mixed product, about 62/38 enclomiphene to zuclomiphene
- Enclomiphene: the isomer described as a pure estrogen receptor blocker
- Zuclomiphene: the isomer with weak estrogen-like activity
That split is the heart of the enclomiphene vs. clomiphene question. One drug contains the other, plus a second ingredient with its own effects.
The two isomers also behave differently over time. Reviews note that zuclomiphene tends to clear from the body more slowly than enclomiphene. That means its share may build up the longer a man stays on clomiphene, which is one reason researchers became interested in studying enclomiphene by itself.
Enclomiphene vs. Zuclomiphene: How Each Acts in the Body
Quick take: Enclomiphene blocks estrogen signals in the brain, so the body makes more of its testosterone. Zuclomiphene behaves partly like estrogen, which may work against that goal.
Your brain watches estrogen levels as a feedback signal. When the hypothalamus senses estrogen, it tells the pituitary to slow down. Enclomiphene blocks those estrogen receptors, so the brain “thinks” levels are low. The pituitary then releases more LH and FSH.
Those two hormones matter. LH tells the testes to make testosterone. FSH supports sperm production. This is a key difference from testosterone replacement therapy (TRT), which raises testosterone directly but tends to suppress LH and FSH.
Zuclomiphene is a different story. The Saffati 2024 review summarized by News-Medical describes it as having weak estrogen-like activity and links it to side effects such as mood changes. In other words, it may nudge the system in a direction men on clomiphene don’t want.
- Enclomiphene: blocks estrogen receptors, supports LH and FSH release
- Zuclomiphene: mild estrogen-like action, linked in reviews to unwanted effects
- TRT: raises testosterone directly, usually lowers LH and FSH
The fertility angle is one reason men ask about these options. In two phase III trials published by Kim and colleagues in 2015, enclomiphene restored testosterone in overweight men with secondary hypogonadism and maintained sperm concentration. A testosterone gel also restored testosterone but markedly reduced sperm counts.
“Clomiphene and enclomiphene are not rivals; one is simply a purified half of the other.”
Enclomiphene vs. Clomiphene Side Effects
Quick take: Reviews suggest that some side effects of clomiphene in men may trace back to zuclomiphene. Enclomiphene still has its own reported side effects, and the research is limited.
This is where Mark’s story connects. His labs improved, yet his mood didn’t. Reviews raise the possibility that the zuclomiphene portion plays a role in experiences like his. That’s a hypothesis supported by mechanism and early data, not a settled fact for every man.
Here is what the Saffati 2024 review and related summaries report:
- Clomiphene (mixed isomers): mood changes are among the effects linked to the zuclomiphene component
- Enclomiphene: headache, nausea, and mood changes have been reported
- Short-term safety: enclomiphene is described as broadly similar to TRT, including a risk of blood clots (venous thromboembolism, or VTE)
- Long-term safety: not yet established for enclomiphene
A few honest limits are worth naming. Most studies are small, many are short, and they mostly measure lab values rather than how men actually feel. Switching from one product to the other is not guaranteed to fix mood or energy. Every man’s response is different.
Because blood clot risk appears on the list, it’s worth knowing the warning signs. Sudden leg swelling or pain, chest pain, or unexplained shortness of breath need prompt medical attention. Tell your doctor about any personal or family history of clots before starting or changing a hormone-related medication.
Regulatory Status: Approved for Women, Unapproved for Men’s Use
Quick take: Clomiphene is FDA-approved for ovulation induction in women, so prescribing it to men is off-label. There is no FDA-approved enclomiphene product in the US.
Off-label prescribing is legal and common. It means a doctor uses an approved drug for a purpose the FDA hasn’t formally reviewed. Clomiphene for men with low testosterone falls into that category, as CompoundingFinder notes.
Enclomiphene’s path has been rockier. In Europe, the EMA’s expert committee issued a negative opinion on an enclomiphene product called EnCyzix in 2018. The committee cited blood clot risk, concluded the benefits did not outweigh the risks, and noted the studies didn’t measure symptoms like libido or bone strength. In the US, the FDA also declined to approve an enclomiphene application in 2015 and asked for more studies.
- Clomiphene: FDA-approved for women’s ovulation induction; off-label in men
- Enclomiphene: no FDA-approved product in the US
- Compounding status: enclomiphene citrate sits in Category 1 of the FDA’s interim 503A bulk substance list, meaning it is under evaluation
- Advisory vote: an FDA advisory committee voted in 2022 against recommending it for the final list; that vote was not binding
Category 1 does not mean approval. It means a substance is still under review, and pharmacies may compound it with a valid prescription while that review is pending. Compounded medications are not FDA-approved, and that includes compounded enclomiphene.
“A medication can be legally compounded and still lack the long-term evidence men deserve to know about.”
Enclomiphene vs. Clomiphene: Questions to Ask Your Doctor About Switching
Quick take: If you feel off on clomiphene, the first step is an honest conversation with your prescriber. Bring specific questions so the visit stays focused.
Your doctor knows your history, your labs, and your goals. They can weigh whether your symptoms are related to the medication, something else, or both. Our guide on how to talk to your doctor about hormone imbalance has tips for preparing.
Questions worth bringing to the appointment:
- Could my mood or energy changes be related to the zuclomiphene in clomiphene?
- What does the evidence say about enclomiphene vs clomiphene for someone like me?
- Is preserving fertility a priority, and how does that affect my options?
- What are the known risks, including blood clots, and how would we monitor for them?
- Since enclomiphene has no FDA-approved product, what would a compounded version mean for me?
- Would TRT or another approach be a better fit for my goals?
- Which labs and symptoms should we track if we make a change?
Write down how you’ve been feeling before the visit. Notes about sleep, mood, energy, and libido give your doctor more to work with than lab numbers alone.
How King’s Pharmacy Supports Men’s Hormone Care
Quick take: We don’t diagnose or decide treatment. We work with your prescriber to fill prescriptions accurately and help you understand your medication.
Our team works directly with physicians across the states we’re licensed in. When a prescriber writes for a compounded medication, our pharmacists prepare it for that individual patient, following state regulations and USP standards.
We also take time to answer questions, and we’re glad to coordinate with your doctor’s office when something needs clarifying. If you’re wondering how your medication works or what to watch for, we listen first. You can learn more on our Men’s Health page or in our overview of BHRT for men and low testosterone.
- Prescription required: every compounded medication needs a valid prescription
- Physician-led care: your doctor makes treatment decisions; we support them
- Ongoing support: easy refills and pharmacist access for questions
The Bottom Line
Mark’s experience isn’t unusual. Good lab numbers and feeling good don’t always line up. The enclomiphene vs clomiphene difference comes down to chemistry: clomiphene contains both isomers, and enclomiphene is just one of them.
Two takeaways matter most. First, zuclomiphene’s estrogen-like activity may explain some side effects men notice on clomiphene, though the research is still small and short-term. Second, enclomiphene has no FDA-approved product, and its long-term safety is unknown. Any change belongs in a conversation with your doctor.
Have questions about whether a compounded medication is right for you? Talk to your prescribing physician, then connect with the pharmacists at King’s Pharmacy and Compounding Center in Irvine, CA to get started. Request a Refill or Contact King’s Pharmacy at 949.387.0780.
Frequently Asked Questions
What is the main difference between enclomiphene and clomiphene?
Clomiphene citrate is a mixture of two isomers: roughly 62% enclomiphene and 38% zuclomiphene. Enclomiphene is just one of those isomers on its own. It blocks estrogen receptors in the brain, while zuclomiphene has weak estrogen-like effects.
Why might a man feel moody on clomiphene even when his testosterone improves?
Reviews link the zuclomiphene portion of clomiphene to side effects such as mood changes. Lab numbers and how a man feels don’t always move together. Mood changes can also have other causes, so it’s important to discuss them with your doctor.
Is enclomiphene FDA-approved?
No. There is no FDA-approved enclomiphene product in the United States. Enclomiphene citrate is in Category 1 of the FDA’s interim 503A bulk substance list, which means it is under evaluation, not approved.
Is clomiphene approved for men?
Clomiphene is FDA-approved for ovulation induction in women. When a doctor prescribes it for a man with low testosterone, that is off-label use. Off-label prescribing is legal and common, but it means the FDA hasn’t formally reviewed that specific use.
Does enclomiphene affect fertility in men?
In two phase III trials published in 2015, enclomiphene restored testosterone while maintaining sperm concentration in overweight men with secondary hypogonadism. Testosterone gel, by contrast, reduced sperm counts. These were limited studies, so men concerned about fertility should speak with their doctor about their situation.




